Literature DB >> 1384322

Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency.

M R Aust1, L G Andrews, M J Barrett, C J Norby-Slycord, M L Markert.   

Abstract

Purine nucleoside phosphorylase (PNP) deficiency is an inherited autosomal recessive disorder resulting in severe combined immunodeficiency. The purpose of this study was to determine the molecular defects responsible for PNP deficiency in one such patient. The patient's PNP cDNA was amplified by PCR and sequenced. Point mutations leading to amino acid substitutions were found in both alleles. One point mutation led to a Ser-to-Gly substitution at amino acid 51 and was common to both alleles. In addition, an Asp-to-Gly substitution at amino acid 128 and an Arg-to-Pro substitution at amino acid 234 were found in the maternal and paternal alleles, respectively. In order to prove that these mutations were responsible for the disease state, each of the three mutations was constructed separately by site-directed mutagenesis of the normal PNP cDNA, and each was transiently expressed in COS cells. Lysates from cells transfected with the allele carrying the substitution at amino acid 51 retained both function and immunoreactivity. Lysates from cells transfected with PNP alleles carrying a substitution at either amino acid 128 or amino acid 234 contained immunoreactive material but had no detectable human PNP activity. In summary, molecular analysis of this patient identified point mutations within the PNP gene which are responsible for the enzyme deficiency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384322      PMCID: PMC1682776     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  50 in total

1.  Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.

Authors:  M A Anderson; J F Gusella
Journal:  In Vitro       Date:  1984-11

2.  Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.

Authors:  P Ponte; S Y Ng; J Engel; P Gunning; L Kedes
Journal:  Nucleic Acids Res       Date:  1984-02-10       Impact factor: 16.971

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Purine nucleoside phosphorylase deficiency: altered kinetic properties of a mutant enzyme.

Authors:  I H Fox; C M Andres; E W Gelfand; D Biggar
Journal:  Science       Date:  1977-09-09       Impact factor: 47.728

5.  Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

Authors:  B S Mitchell; E Mejias; P E Daddona; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.

Authors:  J W Stoop; B J Zegers; G F Hendrickx; L H van Heukelom; G E Staal; P K de Bree; S K Wadman; R E Ballieux
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

7.  Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder.

Authors:  A R Watson; D I Evans; H B Marsden; V Miller; P A Rogers
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

8.  Submolecular characterization of a mutant human purine-nucleoside phosphorylase.

Authors:  J A McRoberts; D W Martin
Journal:  J Biol Chem       Date:  1980-06-25       Impact factor: 5.157

9.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.

Authors:  P Gunning; P Ponte; H Okayama; J Engel; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  4 in total

1.  Purine nucleoside phosphorylase deficiency induces p53-mediated intrinsic apoptosis in human induced pluripotent stem cell-derived neurons.

Authors:  Michael Tsui; Jeremy Biro; Jonathan Chan; Weixian Min; Kerry Dobbs; Luigi D Notarangelo; Eyal Grunebaum
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

2.  Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.

Authors:  Yogita Ghodke-Puranik; Jessica M Dorschner; Danielle M Vsetecka; Shreyasee Amin; Ashima Makol; Floranne Ernste; Thomas Osborn; Kevin Moder; Vaidehi Chowdhary; Elias Eliopoulos; Maria I Zervou; George N Goulielmos; Mark A Jensen; Timothy B Niewold
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

3.  Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency.

Authors:  Raz Somech; Atar Lev; Galia Grisaru-Soen; Shelly I Shiran; Amos J Simon; Eyal Grunebaum
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

4.  Genetic variants associated with arsenic susceptibility: study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes.

Authors:  Sujata De Chaudhuri; Pritha Ghosh; Nilendu Sarma; Papiya Majumdar; Tanmoy Jyoti Sau; Santanu Basu; Susanta Roychoudhury; Kunal Ray; Ashok K Giri
Journal:  Environ Health Perspect       Date:  2008-04       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.